US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Articles published by Elegen

News headline image
Elegen Raises the Bar for Synthetic DNA by Lowering Prices Across Its ENFINIA™ Portfolio
From Elegen
Via Business Wire
News headline image
Elegen Expands ENFINIA™ Platform with IVT Ready DNA to Streamline RNA Therapeutics Development
From Elegen
Via Business Wire
News headline image
Elegen Cuts Pricing for ENFINIA™ DNA, Expanding Access to Next-Generation Cell-Free DNA Manufacturing
From Elegen
Via Business Wire
News headline image
Elegen Now Ships Plasmids Up to 15 kb in Just 10 Business Days, Bringing Unprecedented Speed to Long DNA Synthesis
From Elegen
Via Business Wire
News headline image
Elegen Raises $35 Million in Series B to Accelerate Expansion into Clinical Manufacturing
From Elegen
Via Business Wire
News headline image
Elegen Launches ENFINIA™ DNA Enhancement for Rapid Synthesis of Highly Complex DNA
From Elegen
Via Business Wire
News headline image
Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production Technology
From Elegen
Via Business Wire
Tickers GSK
News headline image
Elegen Early Access Partners Receive High-Complexity, Long DNA Sequences in Rapid Time
From Elegen
Via Business Wire
News headline image
Elegen Launches New Online Ordering Portal for Rapid, High-Accuracy, Long DNA
From Elegen
Via Business Wire
News headline image
Elegen Launches ENFINIA™ DNA, Rapid Long DNA Synthesis to Power the Bioeconomy
From Elegen
Via Business Wire